Cash & Equivalents
Synopsys Cash & Equivalents decreased by 18.6% to $43.11M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 98.8%, from $3.66B to $43.11M. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows a downward trend with a -46.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase signals improved liquidity and financial flexibility, while a decrease may indicate heavy capital expenditure, debt repayment, or aggressive share buybacks.
Detailed definition
Represents the most liquid assets on the balance sheet, including physical currency and short-term investments with matu...
Peer comparison
Large-cap technology peers often maintain high cash balances to fund rapid innovation and offset the cyclical nature of consumer electronics.
cash_and_equivalentsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.39B | $1.44B | $1.13B | $1.58B | $1.39B | $1.42B | $1.16B | $1.55B | $1.69B | $1.44B | $1.12B | $1.51B | $1.84B | $3.90B | $3.66B | $14.12B | $2.53B | $52.98M | $43.11M |
| QoQ Change | — | +3.4% | -21.5% | +39.9% | -12.1% | +2.5% | -18.5% | +33.6% | +9.2% | -14.6% | -22.2% | +34.3% | +22.4% | +111.7% | -6.2% | +286.1% | -82.1% | -97.9% | -18.6% |
| YoY Change | — | — | — | — | -0.1% | -1.1% | +2.7% | -1.9% | +21.8% | +1.5% | -3.1% | -2.7% | +9.1% | +170.5% | +226.2% | +838.3% | +37.5% | -98.6% | -98.8% |
Cash & Equivalents at Other Companies
Frequently Asked Questions
- What is Synopsys's cash & equivalents?
- Synopsys (SNPS) reported cash & equivalents of $43.11M in Q4 2025.
- How has Synopsys's cash & equivalents changed year-over-year?
- Synopsys's cash & equivalents decreased by 98.8% year-over-year, from $3.66B to $43.11M.
- What is the long-term trend for Synopsys's cash & equivalents?
- Over 5 years (2020 to 2025), Synopsys's cash & equivalents has grown at a -46.8% compound annual growth rate (CAGR), from $1.24B to $52.98M.
- What does cash & equivalents mean?
- Money in the bank and very short-term investments that can be turned into cash almost instantly.